CD274 and neoplasm: As indicated by a preclinical study [26] and a very recent analysis on 58 patients with early (and mainly hormone receptor positive) BC patients in a neoadjuvant setting [27] the PD-L1 expression on tumor and stromal cells can change (either increase or decrease) upon cytotoxic treatments.